← Open Payments lookup

KEVIN MILLER: Open Payments

NPI 1205494499 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,430 in 184 payments from 17 companies in 2025. Trend: 2023 $3,144 · 2024 $3,223 · 2025 $3,430

Food & beverage: $3,430
CompanyPaymentsAmount
Aimmune Therapeutics, Inc.35$554
Janssen Biotech, Inc.29$536
ABBVIE INC.32$490
Takeda Pharmaceuticals U.S.A., Inc.23$473
Madrigal Pharmaceuticals13$340
QOL Medical, LLC5$181
Ipsen Biopharmaceuticals, Inc12$150
Phathom Pharmaceuticals, Inc.10$134
Regeneron Healthcare Solutions, Inc.5$102
Gilead Sciences, Inc.4$96

Products named: TREMFYA, ZENPEP, REZDIFFRA, ENTYVIO, RINVOQ, CREON, Sucraid, IQIRVO.

Industry payments across TX — which companies pay providers there.